Propanc Biopharma, Inc. Deferred Offering Costs
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-07-17
- 2025-06-30: Deferred Offering Costs $115.00K.
- 2025-03-31: Deferred Offering Costs $92.12K.
- 2024-12-31: Deferred Offering Costs $52.12K.
- 2024-09-30: Deferred Offering Costs $27.12K.
| Period end | Deferred Offering Costs |
|---|---|
| 2025-06-30 | $115.00K S-1 · filed 2026-07-17 |
| 2025-03-31 | $92.12K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $52.12K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $27.12K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $27.12K 10-Q · filed 2025-05-15 |